Navigation Links
2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
Date:4/22/2009

NEW YORK, April 22 /PRNewswire-USNewswire/ -- Online nominations for the 2009 Prix Galien USA, the highest industry accolade for pharmaceutical research and development, are now being accepted at http://submission.prix-galien-usa.com through Monday, June 15, 2009.

For the first time, the Prix Galien USA will be awarded in three categories that offer broad implications for future biomedical research: best pharmaceutical agent, best biotechnology product and best medical device. All pharmaceutical and biological drugs or devices approved by the U.S. Food and Drug Administration for first or new indications between 1999 and 2008 are eligible for nomination in 2009. The new, decade-long eligibility period will permit the judges to determine both the immediate and the long-term impact these pharmaceuticals, biotechnology products and devices have had on human health and disease.

In 2008, the Prix Galien USA committee recognized Selzentry(TM) (Pfizer Inc.), Isentress(R) (Merck & Co., Inc.), Soliris(R) (Alexion Pharmaceuticals, Inc.), INFUSE(R) (Wyeth) and Revlimid(R) (The Celgene Corporation) all for applications that address pervasive illness and diseases.

The Prix Galien USA award recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines. The award committee comprises 11 individuals including six Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. The 2009 Prix Galien USA award recipients will be honored at its annual gala event on September 30, at the American Museum of Natural History in New York. Winners of the 2009 awards will automatically be eligible for the 2010 International Prix Galien award.

For details about the Prix Galien USA award and committee visit

www.prix-galien-usa.com.

Limited sponsorship opportunities are still available. For more information about sponsoring the 2009 awards ceremony, contact Janet Vinci at (312) 422-0405 or at jvinci@prix-galien-usa.com.


'/>"/>
SOURCE Prix Galien USA
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Prix Galien USA Announces 2008 Final Candidates
2. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
3. Alexions Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
4. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
5. ECBC Now Accepting Applications for 2009 Minority Undergraduate Summer Internship Program
6. GBC Seeks Nominations for Regions Third Annual Bioscience Awards
7. Early-Bird Pricing Ends Soon for MichBio Expo Attendees and Exhibitors; Award Nominations Due Nov. 1
8. Digital pioneer wins national physics prize
9. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
10. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
11. Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: ... plasma-based biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2016 Financial Highlights ... by 21.7% in RMB terms, or increased by 13.6% in ... same quarter of 2015. Gross profit increased ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... Services portfolio to include an array of biochemical analyses critical for Lead ... to drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism ...
(Date:2/23/2017)... 23, 2017  Imanis Life Sciences announced today ... oncolytic vaccinia viruses for virotherapy research. These viruses ... Genelux,s proprietary, vaccinia virus-based technology platform for research ... into a partnership with Genelux to offer researchers, ... for use in research," said Dr. Kah ...
(Date:2/23/2017)... Winston-Salem, NC (PRWEB) , ... February 23, 2017 , ... ... pleased to announce a new partnership with Compass Research . GGI's mission is ... gifting a vaccine to a child in need in honor of each clinical trial ...
Breaking Biology Technology:
(Date:2/3/2017)... 3, 2017 A new independent identity strategy ... LLP (IdSP) . Designed to fill a critical niche ... market, founding partners Mark Crego and ... just in identity expertise that span federal governments, the ... The Crego-Kephart combined expertise has a common theme born ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):